Caseware UK (AP4) 2022.0.179 2022.0.179 2023-03-312023-03-31trueNo description of principal activity2022-04-01false11trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09472238 2022-04-01 2023-03-31 09472238 2021-04-01 2022-03-31 09472238 2023-03-31 09472238 2022-03-31 09472238 c:Director1 2022-04-01 2023-03-31 09472238 d:PlantMachinery 2022-04-01 2023-03-31 09472238 d:PlantMachinery 2023-03-31 09472238 d:PlantMachinery 2022-03-31 09472238 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 09472238 d:FurnitureFittings 2022-04-01 2023-03-31 09472238 d:FurnitureFittings 2023-03-31 09472238 d:FurnitureFittings 2022-03-31 09472238 d:FurnitureFittings d:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 09472238 d:OfficeEquipment 2022-04-01 2023-03-31 09472238 d:OfficeEquipment 2023-03-31 09472238 d:OfficeEquipment 2022-03-31 09472238 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 09472238 d:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 09472238 d:CurrentFinancialInstruments 2023-03-31 09472238 d:CurrentFinancialInstruments 2022-03-31 09472238 d:Non-currentFinancialInstruments 2023-03-31 09472238 d:Non-currentFinancialInstruments 2022-03-31 09472238 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 09472238 d:CurrentFinancialInstruments d:WithinOneYear 2022-03-31 09472238 d:Non-currentFinancialInstruments d:AfterOneYear 2023-03-31 09472238 d:Non-currentFinancialInstruments d:AfterOneYear 2022-03-31 09472238 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2023-03-31 09472238 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2022-03-31 09472238 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2023-03-31 09472238 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2022-03-31 09472238 d:ShareCapital 2023-03-31 09472238 d:ShareCapital 2022-03-31 09472238 d:RetainedEarningsAccumulatedLosses 2023-03-31 09472238 d:RetainedEarningsAccumulatedLosses 2022-03-31 09472238 d:AcceleratedTaxDepreciationDeferredTax 2023-03-31 09472238 d:AcceleratedTaxDepreciationDeferredTax 2022-03-31 09472238 c:FRS102 2022-04-01 2023-03-31 09472238 c:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 09472238 c:FullAccounts 2022-04-01 2023-03-31 09472238 c:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 09472238 2 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure

Registered number: 09472238










HITCHIN OSTEOPATHY LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2023

 
HITCHIN OSTEOPATHY LIMITED
REGISTERED NUMBER: 09472238

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
2,765
6,013

  
2,765
6,013

Current assets
  

Debtors: amounts falling due within one year
 5 
6,733
5,723

Cash at bank and in hand
  
11,880
18,105

  
18,613
23,828

Creditors: amounts falling due within one year
 6 
(12,175)
(13,522)

Net current assets
  
 
 
6,438
 
 
10,306

Total assets less current liabilities
  
9,203
16,319

Creditors: amounts falling due after more than one year
 7 
(6,950)
(9,856)

Provisions for liabilities
  

Deferred tax
 9 
(178)
(771)

  
 
 
(178)
 
 
(771)

Net assets
  
2,075
5,692


Capital and reserves
  

Called up share capital 
  
2
2

Profit and loss account
  
2,073
5,690

  
2,075
5,692


Page 1

 
HITCHIN OSTEOPATHY LIMITED
REGISTERED NUMBER: 09472238
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2023

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 17 October 2023.




R Kraina
Director

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
HITCHIN OSTEOPATHY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
1.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
1.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
1.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
1.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
1.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 3

 
HITCHIN OSTEOPATHY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1.Accounting policies (continued)

 
1.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

 
1.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the following basis.

Depreciation is provided on the following basis:

Plant and machinery
-
33%
straight line
Fixtures and fittings
-
20%
straight line
Office equipment
-
33%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 
HITCHIN OSTEOPATHY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1.Accounting policies (continued)

 
1.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
1.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
1.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
1.12

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the reporting date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Statement of financial position.

 
1.13

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Statement of financial position when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of
Page 5

 
HITCHIN OSTEOPATHY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1.Accounting policies (continued)


1.13
Financial instruments (continued)

financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

 
1.14

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


2.


General information

Hitchin Osteopathy Limited is a private company, limited by shares and incorporated in England
Its registered number is:  09472238
Its Registered Office is: 
11 Bridge Street
Hitchin
Hertfordshire
SG5 2DE


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2022 - 1).

Page 6

 
HITCHIN OSTEOPATHY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

4.


Tangible fixed assets





Plant and machinery
Fixtures and fittings
Office equipment
Total

£
£
£
£



Cost or valuation


At 1 April 2022
-
3,000
10,595
13,595


Additions
210
220
-
430



At 31 March 2023

210
3,220
10,595
14,025



Depreciation


At 1 April 2022
-
2,250
5,332
7,582


Charge for the year on owned assets
70
805
2,803
3,678



At 31 March 2023

70
3,055
8,135
11,260



Net book value



At 31 March 2023
140
165
2,460
2,765



At 31 March 2022
-
750
5,263
6,013

Page 7

 
HITCHIN OSTEOPATHY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

5.


Debtors

2023
2022
£
£


Trade debtors
6,466
5,370

Prepayments and accrued income
267
353

6,733
5,723



6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Bank loans
3,000
3,000

Corporation tax
7,033
7,336

Other creditors
402
1,846

Accruals and deferred income
1,740
1,340

12,175
13,522



7.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Bank loans
6,950
9,856

6,950
9,856


Page 8

 
HITCHIN OSTEOPATHY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

8.


Loans


Analysis of the maturity of loans is given below:


2023
2022
£
£

Amounts falling due within one year

Bank loans
3,000
3,000


3,000
3,000

Amounts falling due 1-2 years

Bank loans
3,000
3,000


3,000
3,000

Amounts falling due 2-5 years

Bank loans
3,950
6,857


3,950
6,857


9,950
12,857



9.


Deferred taxation




2023


£






At beginning of year
(771)


Charged to profit or loss
593



At end of year
(178)

The provision for deferred taxation is made up as follows:

2023
2022
£
£


Accelerated capital allowances
(178)
(771)

(178)
(771)

 
Page 9